From Pulse 2.0 · Amit Chowdhry · · 40s
Mapmygenome Acquires dnaPower For North American Health Expansion
Mapmygenome acquires dnaPower to boost precision health testing across North America.
In brief
Mapmygenome acquires dnaPower to boost precision health testing across North America. Mapmygenome acquired dnaPower to expand its North American precision health platform with DNA, microbiome, and longevity testing capabilities. Originally reported by Pulse 2.0.
Acquisition Details
Mapmygenome completed acquisition of Vancouver-based dnaPower to expand North American precision health operations.
Platform Integration
The combination merges dnaPower’s consumer reach with Mapmygenome’s multi-omics analytics and clinical testing capabilities.
New Testing Offerings
The platform now supports DNA, microbiome, pharmacogenetics, longevity, and AI-driven multi-omics testing for preventive healthcare.
Centralized Hub
Mapmygenome plans a Vancouver processing hub operating under CAP-accredited and ISO-certified protocols.
What matters most
Mapmygenome acquired dnaPower to expand its North American precision health platform with DNA, microbiome, and longevity testing capabilities.
